Bupropion is an antidepressant that also promotes weight loss, making it unusual among psychiatric medications. It is not FDA-approved as a standalone weight loss drug, but it is one half of Contrave, an FDA-approved weight loss pill that combines bupropion with naltrexone. On its own, bupropion has shown meaningful results in clinical trials: obese adults lost 7.2% to 10.1% of their body weight over 24 weeks, depending on the dose.
Why Bupropion Causes Weight Loss
Bupropion blocks the reabsorption of two brain chemicals, dopamine and norepinephrine, keeping them active longer. Both play a role in regulating appetite and how rewarding food feels. The drug also stimulates a group of neurons in the hypothalamus called POMC neurons, which release a hormone with appetite-suppressing properties. This is the same pathway that several newer obesity medications target.
Because it works on dopamine and norepinephrine rather than serotonin, bupropion doesn’t cause the weight gain and increased appetite commonly seen with SSRIs and other antidepressants. That distinction is a major reason clinicians choose it for patients who are concerned about gaining weight on an antidepressant.
What the Clinical Trials Found
The most robust standalone data comes from a 48-week, double-blind, placebo-controlled trial of obese adults. Participants were assigned to a placebo, 300 mg per day of bupropion SR, or 400 mg per day, all alongside a lifestyle intervention program. At 24 weeks, the placebo group had lost 5.0% of their initial body weight. The 300 mg group lost 7.2%, and the 400 mg group lost 10.1%. Both bupropion groups maintained most of that loss through 48 weeks, holding at 7.5% and 8.6% respectively. The weight loss was dose-related, meaning the higher dose produced better results.
These numbers reflect what happens when bupropion is paired with diet and exercise changes. The medication is not a substitute for lifestyle modification; it amplifies the effect of those changes.
How It Compares to Other Weight Loss Medications
When stacked against other FDA-approved obesity medications, bupropion/naltrexone (Contrave) falls on the lower end for raw weight loss numbers. A network meta-analysis comparing the major options at one year found the following average weight loss from baseline:
- Semaglutide: 13.7%
- Phentermine/topiramate: 9.1%
- Liraglutide: 5.0%
- Bupropion/naltrexone: 4.6%
Semaglutide (the active ingredient in Wegovy and Ozempic) clearly leads the pack. But bupropion/naltrexone is an oral pill rather than an injection, and it can serve double duty for people who also have depression, seasonal affective disorder, or are trying to quit smoking. For someone who needs an antidepressant and would also benefit from modest weight loss, bupropion offers something the others don’t.
Standalone Bupropion vs. the Combination Pill
The FDA-approved weight loss product is Contrave, which pairs bupropion with naltrexone. Naltrexone blocks opioid receptors in the brain, which prevents a feedback loop that would otherwise dampen bupropion’s appetite-suppressing effect. Together, the two drugs sustain the appetite reduction longer than bupropion alone.
Bupropion by itself is sometimes prescribed off-label for weight management, particularly when the primary reason for prescribing it is depression or smoking cessation and weight loss is a welcome secondary benefit. Clinicians favor it in these cases because of its favorable profile: unlike most antidepressants, it carries a low risk of both weight gain and sexual dysfunction.
Timeline for Seeing Results
Weight loss with bupropion is gradual. In clinical trials, the most significant changes appeared over the first 24 weeks. Most participants saw steady, progressive loss during that period rather than a dramatic early drop. After 24 weeks, weight generally stabilized, with participants maintaining their losses through 48 weeks rather than continuing to lose. If you’ve been taking bupropion for several months without any noticeable change in weight, the medication is unlikely to produce significant loss on its own for you.
Does It Help With Binge Eating?
Despite its appetite-suppressing effects, bupropion does not appear to help with binge eating disorder. A randomized controlled trial gave 300 mg per day of bupropion or a placebo to overweight women with binge eating disorder for eight weeks. While the bupropion group did lose more weight, there was no meaningful difference between the groups in binge eating frequency, food cravings, eating disorder symptoms, or depression. Binge eating remission rates were 42% for bupropion versus 27% for placebo, a gap that was not statistically significant. The takeaway: bupropion may help you eat less overall, but it doesn’t specifically address the compulsive patterns behind binge eating.
Who Should Not Take Bupropion
Bupropion lowers the seizure threshold, which creates hard limits on who can safely use it. It is contraindicated for anyone with a seizure disorder, anorexia nervosa, or bulimia. People going through alcohol or benzodiazepine withdrawal, those with a history of significant head trauma, and anyone with severe liver disease should also avoid it. If you’ve taken a monoamine oxidase inhibitor (a type of older antidepressant) within the past 14 days, bupropion is off the table due to the risk of dangerous spikes in blood pressure.
The eating disorder restriction is particularly relevant for people seeking bupropion for weight loss. Restrictive eating patterns, purging behaviors, and the electrolyte imbalances that come with them all increase seizure risk, making bupropion genuinely dangerous in that context rather than just inadvisable.
What to Realistically Expect
Bupropion is not in the same league as semaglutide for pure weight loss. Its strength lies in being a versatile medication that treats depression, helps with smoking cessation, and produces moderate weight loss as part of the package. For someone who would benefit from an antidepressant anyway, losing 5% to 10% of body weight over six months is a meaningful bonus. For someone whose only goal is maximum weight reduction, newer GLP-1 medications will likely produce better results. The decision usually comes down to what else you need the medication to do for you.